About this Journal Submit a Manuscript Table of Contents
Journal of Aging Research
Volume 2012 (2012), Article ID 172492, 9 pages
http://dx.doi.org/10.1155/2012/172492
Review Article

Role of Exercise Therapy in Prevention of Decline in Aging Muscle Function: Glucocorticoid Myopathy and Unloading

Institute of Exercise Biology and Physiotherapy, University of Tartu, Ravila 14a, 50411 Tartu, Estonia

Received 1 December 2011; Accepted 14 May 2012

Academic Editor: Barbara Tettenborn

Copyright © 2012 Teet Seene and Priit Kaasik. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Changes in skeletal muscle quantity and quality lead to disability in the aging population. Physiological changes in aging skeletal muscle are associated with a decline in mass, strength, and inability to maintain balance. Glucocorticoids, which are in wide exploitation in various clinical scenarios, lead to the loss of the myofibrillar apparatus, changes in the extracellular matrix, and a decrease in muscle strength and motor activity, particularly in the elderly. Exercise therapy has shown to be a useful tool for the prevention of different diseases, including glucocorticoid myopathy and muscle unloading in the elderly. The purpose of the paper is to discuss the possibilities of using exercise therapy in the prevention of glucocorticoid caused myopathy and unloading in the elderly and to describe relationships between the muscle contractile apparatus and the extracellular matrix in different types of aging muscles.

1. Introduction

Aging is a multifactorial process influenced by biological, physiological, psychological, and social changes. The biological and physiological changes are primarily associated with a decline in muscle mass, strength, endurance and the inability to maintain balance [13]. Physical risk factors for falling, such as muscle weakness and an inability to maintain static or dynamic balance, lead to severe injury in the elderly [3]. Changes in skeletal muscle quantity and quality lead to disability in the aging population [4].

The rate of muscle loss has been estimated to range from 1% to 2% per year past the age of 50, as a result of which 25% of people under the age of 70 and 40% over the age of 80 are sarcopenic [5, 6]. In both young and aged skeletal muscle, it has been shown that oxidative stress increases in response to unloading [7] and may have an important role in mediating muscle atrophy [8]. It has also been proposed that changes caused by aging and unloading are muscle specific [9]. Muscle unloading results in a decrease in the number of myonuclei and an increase in the number of apoptotic myonuclei in skeletal muscle [10]. Heat-shock protein (HSP) 70 inhibits caspase-dependent and caspase-independent apoptotic pathways and may function in the regulation of muscle size by inhibition of necrotic muscle fiber distribution and apoptosis in aged muscle [11, 12]. The decline of muscle mass is primarily caused by type II fiber atrophy and loss in the number of muscle fibers. Increased variability in fiber size, accumulation of nongrouping, scattered and angulated fibers, and expansion of extracellular space are characteristic to muscle atrophy [13, 14]. Loss of fiber number as well as decreased production of anabolic hormones, for example, testosterone, growth hormone, insulin-like growth factor 1 (IGF-1), and an increase in the release of catabolic agents are principal causes of sarcopenia, and interleukin-6 has also been shown to amplify the rate of muscle wasting [15, 16].

Aging skeletal muscle becomes less powerful, fat is redistributed from the depot to muscle [17], and altered collagen synthesis and posttranslational changes in the structure of collagen reduce the elasticity of ligaments [18, 19].

The properties of muscle strength and stiffness that control balance between the ability of muscle fibers to resist stretching depend on the degree of cross-linking of collagen molecules. With age, the number of cross-links increases and makes the collagen fibers too stiff for optimal function [20].

Skeletal muscle reloading after unloading has been shown to increase the recovery of motor activity, which is as fast as the recovery of muscle strength, but mechanical properties depend on the metabolism and regeneration of the muscle structures from disuse atrophy [4]. The qualitative remodeling of contractile proteins plays a certain role in impaired locomotion and general weakness in aging. Thus, when atrophic muscle becomes active again, muscle mass increases in a relatively short period of time but the recovery of muscle strength takes much longer [21].

Dexamethasone treatment increased aging muscle wasting much more than in the young [22, 23] and the main reason is the loss of myofibrillar proteins from muscle [22, 24]. The catabolic action of glucocorticoids on skeletal muscle was found to depend on the functional activity of muscle [25, 26]. Exercise with simultaneous glucocorticoid treatment is an effective measure in retarding skeletal muscle atrophy [27, 28] and provides protection against one of the major effects of glucocorticoid-muscle wasting [29]. The search for possibilities to rehabilitate the loss of physical function by exercise therapy in the elderly to prevent diseases is one of the challenges nowadays caused by the increase in the number of aging people in the society. The capacity to evoke structural and functional rearrangements in aging skeletal muscle depends on the oxidative potential of the fibers [30]. The integral indicator of muscle protein metabolism, the turnover rate, provides a mechanism by which strength exercise can change the renewal of contractile proteins in accordance with the needs of muscle contractile apparatus [31]. As oxidative capacity of skeletal muscle decreases in the elderly, endurance exercises seems to be effective in its restoration as it stimulates mitochondrial biogenesis and improves their functional parameters [32, 33]. Both, strength and endurance exercise seem to be promising tools for aging-related disease prevention.

In the present paper, we will discuss recent evidence of exercise therapy in the prevention of glucocorticoid caused myopathy and in case of skeletal muscle unloading, what is characteristic in aging population. We will describe the relationships between the muscle contractile apparatus and the extracellular matrix (ECM) in different types of aging muscle and changes in muscle strength, endurance, and motor activity.

2. Glucocorticoid-Caused Myopathy in Aging Muscle

The anti-inflammatory effect of glucocorticoids is the reason for their wide use in various clinical scenarios. A side effect of glucocorticoids is muscle atrophy (Figure 1). It is well known that glucocorticoid-caused myopathy as well as Cushing’s disease lead to a marked reduction in muscle mass, wasting of muscle, loss of strength, and selective atrophy of fast-twitch (FT) muscle fibers [34].

172492.fig.001
Figure 1: Effects of aging, unloading, and glucocorticoid treatment on skeletal muscle quantity and quality.

Aging-caused sarcopenia is associated with muscle weakness and impaired locomotion. Dexamethasone treatment significantly decreases muscle strength and motor activity of laboratory animals [23] and humans [22]. The reduced muscle mass in aging and dexamethasone treatment reflect a loss of myofibrillar proteins [4, 22, 24]. In both laboratory animals and humans, the synthesis rate of myofibrillar but not of sarcoplasmatic proteins decreases with age [22]. The treatment of adult and aged laboratory animals with dexamethasone leads to muscle wasting, but this effect was much more rapid in aged animals [35]. One of the reasons for this is that glucocorticoids decrease the stimulatory effect of insulin and IGF-1 in the skeletal muscle of old rats twice as much as in adults [36] and increase the expression of myostatin, a negative regulator of skeletal muscle [37]. In FT muscle fibers, an excess of glucocorticoids causes a break-down of thick and thin myofilaments and disintegration of individual myofibrils [38].

2.1. Role of Cellular and Extracellular Compartments in Changes of Muscle Strength and Motor Activity in Aging Myopathic Muscle

One of the important consequences of aging is impaired locomotion and general weakness [22]. Daily motor activity of old rats has a tendency to decrease in comparison with young rats. Dexamethasone treatment significantly reduced daily motor activity in both young- and old-age groups [39]. It has been shown there is a decline in muscle strength in atrophic muscle [40]. The qualitative remodeling of contractile proteins probably plays a certain role in this. Dexamethasone treatment decreased grip strength in both age groups but significantly more in the old than in the young group [23, 39]. It seems that in the everyday life of senescent rats, a decrease in muscle strength plays a more important role than daily motor activity.

The intensity of regeneration depends on the number of satellite cells under the basal lamina of muscle fibers, the size of the muscle, the type of injury, and the twitch characteristics of the muscle [30, 4143]. Autografting of gastrocnemius muscle in old animals shows that regeneration proceeds significantly more slowly in comparison with young animals. Dexamethasone treatment decreased regeneration capacity both in young and old animals. Slower regeneration in old animals and after dexamethasone treatment in young and old groups is in good correlation with the decreased number of satellite cells [39]. Previous work has shown that dexamethasone treatment caused destructive changes in satellite cells on the ultrastructural level, which are similar to mother cell damage [38]. Myosin heavy chain (MyHC) composition during regeneration shifts from fast to slower type and this process is regulated by the cycle of denervation and reinnervation in regenerating skeletal muscle fibers [41].

Dexamethasone treatment led to quite similar results both in the young and the old but these changes are more significant in the aging group. Both aging and dexamethasone induced sarcopenic muscles have diminished regenerative capacity [39].

An excess of glucocorticoids has some similarities in its effect on the intracellular and extracellular compartments of skeletal muscle, for example, the decreased synthesis of proteins [34, 44]. The downregulation of collagen synthesis during dexamethasone administration shows that ECM components decrease [44]. As shown previously [38], MyHC synthesis rate only decreased in FT muscles, while the expression of collagen I, III, and IV mRNA decreased in both FT and slow-twitch (ST) muscles. It seems that dexamethasone treatment similarly influences fibril- and network-forming collagen expression in ST and FT muscles but differs at this point from contractile protein myosin synthesis, which was depressed only in FT muscles [45].

The second principal difference between contractile proteins and ECM during an excess of glucocorticoids is the degradation rate of proteins. Dexamethasone-increased the degradation of contractile proteins in skeletal muscle about two times but the expression of matrix metalloproteinase-2 (MMP-2) mRNA did not simultaneously significantly change although the degradation of collagens occurs mainly through MMP activity [46]. This is surprising as it was shown earlier that ST muscles contain significantly more collagen than FT muscles [47].

The concentration of endomysial collagen is higher around FT fibers [48], but as the downregulation of synthesis and unchanged degradation of type IV collagen are very similar to fibrillar collagen, and this shows that mechanical stability in skeletal muscle fibers, which is ensured by collagen IV, does not differ between ST and FT fibers. The effect of glucocorticoids on muscle weakness is applied through damaged contractile machinery of FT muscle fibers’ intracellular compartment [23, 45].

2.2. Regeneration Capacity of Aging Myopathic Muscle

It has been shown that the turnover rate of contractile proteins in aging animals [49] and in young adults after the infusion of glucocorticoids decreases [23], and precursor cells required for muscle regrowth are morphologically and functionally damaged [38]. These changes together may be one of the reasons for sarcopenia (Figure 1). The mechanisms responsible for sarcopenia in aged skeletal muscle are largely unknown, but muscle satellite cells required for the repair of fibers certainly exhibit impaired activation [50] and proliferation [51] compared to young muscle.

Autografting of skeletal muscle has been used as a model of muscle regeneration. Higher oxidative capacity of muscle tends to ensure its faster regeneration [5254]. It has been shown that the synthesis rate of contractile proteins depends on muscle oxidative potential [55]. In aging rats, the MyHC and actin synthesis rates decrease by about 30% and 23%, respectively [39]. It is known that aging is related to a dramatically reduced MyHC synthesis rate [56] without any change in MyHC on the transcriptional level [57]. Muscle wasting is also associated with increased protein degradation, particularly that of contractile proteins (Figure 1). Accumulation of abnormal proteins during aging is believed to result from defects in protein breakdown but very few experimental data support this hypothesis [22]. Results show that the degradation rate of contractile proteins in skeletal muscle during aging increased about two times, and dexamethasone treatment significantly increased the degradation rate in both age groups [39]. Previous works have shown that dexamethasone associated degradation starts from the periphery of myofibrils in muscle fibers with low oxidative potential [38]. This destruction process starts from myosin filaments and thereafter spreads all over the myofibrillar apparatus [38]. It has been shown that contractile proteins turned over slowly in old animals and subjects as well as in young rodents after dexamethasone treatment [34].

3. Effect of Unloading on Aging Skeletal Muscle

Aging is associated with a decline in skeletal muscle mass (sarcopenia), strength (dynapenia), and endurance (Figure 1). The term dynapenia was used to describe the age-related loss of muscle strength by Clark and Manini [58, 59]. Muscle unloading as a result of sedentary lifestyle, bed rest, spaceflight, and hindlimb suspension lead the skeletal muscle to microcirculatory disturbances, atrophy, protein loss, changes in contractile properties, and fiber-type switching [60].

The gradual development of functional limitations over an extended period of time is affected by the natural age-related decline in physical and biological properties, which already starts in midlife and increases the risk for a decline in physical functioning in later life [61].

During aging, the physical system suffers to a different extent and rate in diverse parts of the body. This results in reduced functional reserve, a decrease in vital capacity, deterioration of the capillary blood supply, and a decrease in muscle mass [62].

Living a sedentary life in older age, inactivity can lead to a loss of functional health due to deficits in muscle strength, endurance and flexibility [62]. “Use it or lose it” has proved to be a key rule for maintaining physical independence in the elderly [63]. One of the reasons for the development of muscle weakness in the elderly is decreased physical activity. Inactivity and aging cause a marked relative increase in the endo- and perimysial connective tissue, which results in changes in the mechanical properties of skeletal muscle [64]. Myofibrillar basal lamina becomes thicker and more rigid with age and increased cross-linking of collagen molecules make fibrils more resistant to degradation by collagenase [65]. The muscle tissue response to unloading seems to be more expressed than the connective tissue response [18, 66]. The connective structures are protected from rapid changes in tissue mass while muscle, which is known to act as a protein store for the organism, is subject to substantial and fast changes in tissue mass. Despite the small changes in connective tissue mass, important changes occur in the tissue structures during unloading and aging [4], which lead to the development of muscle weakness in case of restricted physical activity in the elderly.

4. The Preventive Role of Exercise Therapy on Aging Unloaded and Myopathic Muscle

Exercise therapy is a wide and systematic approach to the regular use of specific movements to improve different body functions, mobility, and fitness (Figure 2). Exercise therapy is a useful tool for the prevention and management of different injuries and diseases. On many occasions, specific exercise programs are tailored for rehabilitation needs. For example, in case of glucocorticoid caused myopathy, both endurance and strength exercise training has been shown to play a preventive role in the development of muscle atrophy, but a combination of both with different frequency, intensity and duration seems to be more effective (Figure 2).

172492.fig.002
Figure 2: Effect of exercise therapy on aging, unloading, and glucocorticoid caused myopathic skeletal muscle.

More than four decades ago, the preventive role of exercise in the development of muscle atrophy during glucocorticoid administration was shown [25]. From the historical viewpoint, endurance exercise has been found to be an effective measure in retarding skeletal muscle atrophy associated with the administration of glucocorticoids [26, 29, 67]. From the contraction nature, four model systems have given the desired effect: endurance exercise, strength exercise, muscle functional overload, and in vitro cell culture stimulation [68]. Later intensive short-lasting exercise training has shown to have an anticatabolic effect on the contractile apparatus and the ECM of skeletal muscle [69]. Glucocorticoids increased myofibrillar protein degradation in FT muscles, while fibril- and network-forming collagen specific mRNA levels decreased at the same time in FT and ST muscles [45]. Both the myofibrillar apparatus and the ECM play a crucial role in changes of muscle strength during glucocorticoid administration and following muscle loading [70].

4.1. Effect of Resistance Exercise Training

Muscle atrophy contributes to but does not completely explain the decrease in force in the elderly. The age-related decrease in muscle mass and strength is a consequence of the complete loss of fibers associated with the decrease in the number of motor units and fiber atrophy [71]. In recent years, resistance exercise has become one of the fastest growing forms of physical activity for different purposes: improving athletic performance, enhancing general health and fitness, rehabilitation after surgery or an injury, or just for the pleasure of exercise [72]. Resistance exercise has shown to be an effective measure in the elderly, improving glucose intolerance, including improvements in insulin signaling defects, reduction in tumor necrosis factor-α, increases in adiponectin and IGF-1 concentrations, and reductions in total and abdominal visceral fat [73]. Resistance exercise improves skeletal muscle metabolism and through it muscle function in the elderly and their life quality [4].

Resistance exercise enhances the synthesis rate of myofibrillar proteins but not that of sarcoplasmic proteins [74] and this is related to mammalian target of rapamycin by activating proteins within the nitrogen-activated proteinkinase signaling [75]. A significant difference was observed between previously trained young and old participants in recovery from resistance training [76]. These results suggest a more rapid recovery in the young group. It seems that recovery from more damaging resistance exercise is slower as a result of age, whereas there are no age-related differences in recovery from less damaging metabolic fatigue [77].

It has been shown that resistance training, during which the power of exercise increased less than 5% per session, caused hypertrophy of both FT and ST muscle fibers, an increase of myonuclear number via fusion of satellite cells with damaged fibers or the formation of new muscle fibers as a result of myoblasts’ fusion in order to maintain myonuclear domain size [78].

It has been shown that contractile proteins turned over faster in type I and IIA fibers than in IIB fibers and the turnover rate of skeletal muscle proteins in skeletal muscle depends on the functional activity of the muscle [30]. The turnover rate of myofibrillar proteins in aging skeletal muscle is related to the changes in MyHC isoforms’ composition [4]. The effect of resistance training on the increase of the turnover rate of skeletal muscle contractile proteins in old age is relatively small [4]. Adaptational changes first appeared in newly formed or regenerating fibers and these changes lead to the remodeling of the contractile apparatus and an increase in the strength generating capability of muscle. These changes are more visible in muscle fibers with higher oxidative capacity. The recovery of locomotory activity after unloading is as fast as the recovery of muscle strength. It is related to the regeneration of muscle structure form disuse atrophy [79]. This fact suggests the presence of functionally immature muscle fibers during the recovery process following disuse atrophy [79]. So, the recovery of skeletal muscle mechanical properties depends on the structural and metabolic peculiarities of the skeletal muscle [30]. As a complex of factors contributes to the development of muscle wasting and weakness in the elderly, skeletal muscle unloading and glucocorticoid caused myopathy, it is complicated to find one certain measure for rehabilitation. As lack of strength is one of the central reasons for muscle weakness, it seems to be most realistic to use resistance training for this purpose in the elderly. Resistance training is a strong stimulus for muscle metabolism in the elderly, particularly for the contractile machinery of muscle (Figure 2).

4.2. Effect of Endurance Exercise Training

As oxidative capacity of skeletal muscle decreases in the elderly, endurance training is effective in stimulating mitochondrial biogenesis and improving their functional parameters [32, 33]. In combination with resistance training, the oxidative capacity and subsequently the turnover rate of contractile proteins in elderly skeletal muscle increases. This increase of the turnover rate of muscle proteins leads to the increase in skeletal muscle plasticity. It has recently been shown that the plasticity of individual development in the elderly makes it possible to modify the age-associated decline even in maximal physical performance [80]. Another positive influence of endurance training in the elderly is related to an increase in the ability of cardiovascular factors and to a lesser extent, to an increase in muscle mitochondrial concentration and capacity [81].

The increase in muscle oxidative capacity and contractile property is an effective measure for enhancing life quality in the elderly by improving skeletal muscle functional capacity and plasticity. It has recently been shown that the individual development of muscle plasticity in the elderly makes it possible to modify the age-associated decline even in maximal physical performance at least for some time [80]. The higher aerobic capacity in trained elderly people is related to an increase in the abilities of the cardiovascular system and to the lesser extent to an increase in muscle mitochondrial concentration [81]. It means that regular aerobic activity provides a foundation for an increase in muscle oxidative capacity in the elderly (Figure 2). It is useful to repeat the viewpoint of Suominen [80] that adequate physical performance is an essential element of a healthy and productive life among the elderly. Netz [82] studied the effect of physical activity on the moderating role of fitness improvement and mode of exercise to the potential mechanisms for explaining the physical activity affect relationship and found that neither improved fitness nor exercise modality serve as moderators of physical activity effect on affect. However, with older age managing everyday activities becomes less self-evident although there are gender differences in physical functioning [83]. Functional limitation is an objective measure of the consequences of disease and impairment [84].

It seems that the turnover rate of contractile proteins provides a mechanism by which the effect of exercise causes changes in accordance with the needs of the contractile apparatus. As the contractile protein turnover rate depends on the oxidative capacity of muscle and muscle oxidative capacity decreases in the elderly, it is obvious that endurance exercise stimulates an increase in the oxidative capacity of skeletal muscle by an increase in mitochondrial biogeneses and supports faster protein turnover during resistance training in order to increase muscle function (Figure 2). It has been shown that the aging-associated reduction in AMP-activated protein kinase (AMPK) activity may be a factor in reduced mitochondrial function [85]. In response to contractile activity, AMPK activation was registered only in aging FT muscles [86]. It is known that AMPK is activated in response to endurance exercise [87] and related to the metabolic adaptation of skeletal muscle. Later it has been shown that 𝛼 1 isoform of AMPK is the regulator of skeletal muscle growth, but not of metabolic adaptation [66]. As factors such as health, physical function, and independence constitute components of quality of life in the elderly, physiological functioning of skeletal muscle in the elderly has significance in determining the ability to maintain independence and an active interaction with the environment [4, 88]. According to Kramer and Erickson [89], successful aging is guaranteed when elderly people use widespread participation in low-cost and low-tech exercise for further improving their fitness and reducing the risk of disability.

4.3. Effect of Concurrent Strength and Endurance Exercise Training

Concurrent training for strength and endurance has shown to decrease the gain in muscle mass in comparison with training for strength alone [90]. This effect was explained by AMPK blocking the activation of mammalian target of rapamycin complex-1 (TORC 1) by phosphorylating and activating the tuberous sclerosis complex-2 (TSC 2) [91]. This interference in skeletal muscle strength development was also explained by alterations in the protein synthesis induced by the high volume of endurance exercise or by frequent exercise training sessions [92] or was related to impairment of neural adaptations [93].

Concurrent strength and endurance exercise training in elderly men has shown that strength gain was similar to that observed with strength training alone, although strength training volume was half of that strength training alone [94]. Using lower training volumes in concurrent training in older men [95] in comparison with endurance and resistance training alone leads to similar strength enhancement with no presence of interference in this population [96]. In the elderly population, improvement in both strength and cardiorespiratory fitness is important and concurrent training is the best strategy to enhance cardiorespiratory fitness as it has widely been shown in the literature [93].

5. Conclusions and Future Directions

Changes in skeletal muscle mass and function with advancing age are reasons for disability in the aging population. Glucocorticoid treatment and skeletal muscle unloading lead to muscle atrophy, loss of myofibrillar proteins, changes in ECM and a decrease in muscle strength and motor activity. As a complex of factors supporting development of skeletal muscle wasting and weakness in the elderly in case of muscle unloading and glucocorticoid caused myopathy it is complicated to find one certain facility for rehabilitation. As the lack of strength is one of the central reasons in muscle weakness, it seems to be promising to use resistance training for this purpose in elderly. On the other hand, as oxidative capacity of skeletal muscle decreases in the elderly and endurance training is known to be an effective tool in the stimulation of mitochondrial biogenesis and improving their functional parameters, it seems that in combination with resistance exercise training, the oxidative capacity and subsequently the turnover rate of muscle contractile proteins in elderly skeletal muscle increases and leads to an increase in muscle plasticity. Physiological functioning of skeletal muscle in the elderly has significance in determining the ability to maintain independence and an active interaction with the environment.

Aging-associated reductions in AMPK activity may be a factor in the reduced mitochondrial function and AMPK is activated in response to endurance exercise, which explains the use of endurance exercise training in the prevention of disability and diseases. Frailty due to sarcopenia and dynapenia are proved reasons for the loss of an active interaction with the environment and loss of independence in the elderly, and predicate the use of resistance exercise for purposes of increasing muscle strength. The use of concurrent strength and endurance training in the prevention of muscle atrophy in the elderly population and the connection with anabolic and anticatabolic processes in skeletal muscle has not yet been elucidated. Future studies should focus on concurrent strength and endurance exercise effects on the prevention of skeletal muscle atrophy in the elderly during unloading and glucocorticoid treatment. The question is whether and in what conditions AMPK blocks the activation of TORC 1 by activating the TSC 2 during concurrent strength and endurance exercise in elderly skeletal muscle. To the best of our knowledge, it seems that concurrent training is an auspicious tool in the prevention or at least in the deceleration of the development of sarcopenia and dynapenia in the elderly. The important step is to optimize exercise therapy programs with respect to the interaction between signaling pathways for contractile and mitochondrial protein synthesis and degradation in the aging unloaded and myopathic population. This strategy to work out concurrent strength and endurance exercise programs in the elderly is complicated as it is unclear whether a muscle fiber is capable to undergo hypertrophy and maintain endurance capacity at the same time. It is clear that an exercise program has to be composed, which enables the recruitment of both ST and FT muscle fibers for the purpose of contributing the signaling pathways to accelerate protein turnover in aging skeletal muscle.

Acknowledgments

This study was supported by the funds of the Ministry of Education and Research of the Republic of Estonia, Research Project no. TKKSB1787. The authors would like to thank Helen Kaptein for English language editing and Piret Pärsim for technical expertise.

References

  1. J. M. Haus, J. A. Carrithers, S. W. Trappe, and T. A. Trappe, “Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle,” Journal of Applied Physiology, vol. 103, no. 6, pp. 2068–2076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Trappe, “Influence of aging and long-term unloading on the structure and function of human skeletal muscle,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 459–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. D. S. Santos, E. E. M. Dantas, and M. H. R. Moreira, “Correlation of physical aptitude; functional capacity, corporal balance and quality of life (QoL) among elderly women submitted to a post-menopausal physical activities program,” Archives of Gerontology and Geriatrics, vol. 53, pp. 344–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Seene, P. Kaasik, and E. M. Riso, “Review on aging, unloading and reloading: changes in skeletal muscle quantity and quality,” Archives of Gerontology and Geriatrics, vol. 54, no. 2, pp. 374–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Marzetti and C. Leeuwenburgh, “Skeletal muscle apoptosis, sarcopenia and frailty at old age,” Experimental Gerontology, vol. 41, no. 12, pp. 1234–1238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Hiona and C. Leeuwenburgh, “The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging,” Experimental Gerontology, vol. 43, no. 1, pp. 24–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M. Siu, E. E. Pistilli, and S. E. Alway, “Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading,” Journal of Applied Physiology, vol. 105, no. 6, pp. 1695–1705, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. K. Powers, A. N. Kavazis, and J. M. McClung, “Oxidative stress and disuse muscle atrophy,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2389–2397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Luden, K. Minchev, E. Hayes, E. Louis, T. Trappe, and S. Trappe, “Human vastus lateralis and soleus muscles display divergent cellular contractile properties,” American Journal of Physiology, vol. 295, no. 5, pp. R1593–R1598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Leeuwenburgh, C. M. Gurley, B. A. Strotman, and E. E. Dupont-Versteegden, “Age-related differences in apoptosis with disuse atrophy in soleus muscle,” American Journal of Physiology, vol. 288, no. 5, pp. R1288–R1296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Sreedhar and P. Csermely, “Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review,” Pharmacology and Therapeutics, vol. 101, no. 3, pp. 227–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ogata, S. Machida, Y. Oishi, M. Higuchi, and I. Muraoka, “Differential cell death regulation between adult-unloaded and aged rat soleus muscle,” Mechanisms of Ageing and Development, vol. 130, no. 5, pp. 328–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. H. Kim, H. B. Kwak, C. Leeuwenburgh, and J. M. Lawler, “Lifelong exercise and mild (8%) caloric restriction attenuate age-induced alterations in plantaris muscle morphology, oxidative stress and IGF-1 in the fischer-344 rat,” Experimental Gerontology, vol. 43, no. 4, pp. 317–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. W. Buford, S. D. Anton, A. R. Judge et al., “Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy,” Ageing Research Reviews, vol. 9, no. 4, pp. 369–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Roubenoff, “Catabolism of aging: is it an inflammatory process?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, no. 3, pp. 295–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Goldspink and S. D. R. Harridge, “Growth factors and muscle ageing,” Experimental Gerontology, vol. 39, no. 10, pp. 1433–1438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Toth and A. Tchernof, “Lipid metabolism in the elderly,” European Journal of Clinical Nutrition, vol. 54, supplement 3, pp. S121–S125, 2000. View at Scopus
  18. M. Kjær, P. Magnusson, M. Krogsgaard et al., “Extracellular matrix adaptation of tendon and skeletal muscle to exercise,” Journal of Anatomy, vol. 208, no. 4, pp. 445–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Heinemeier, J. L. Olesen, F. Haddad, P. Schjerling, K. M. Baldwin, and M. Kjaer, “Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle,” Journal of Applied Physiology, vol. 106, no. 1, pp. 178–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Freemont and J. A. Hoyland, “Morphology, mechanisms and pathology of musculoskeletal ageing,” Journal of Pathology, vol. 211, no. 2, pp. 252–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Pottle and L. E. Gosselin, “Impact of mechanical load on functional recovery after muscle reloading,” Medicine and Science in Sports and Exercise, vol. 32, no. 12, pp. 2012–2017, 2000. View at Scopus
  22. D. Attaix, L. Mosoni, D. Dardevet, L. Combaret, P. P. Mirand, and J. Grizard, “Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 10, pp. 1962–1973, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Seene, P. Kaasik, A. Pehme, K. Alev, and E. M. Riso, “The effect of glucocorticoids on the myosin heavy chain isoforms' turnover in skeletal muscle,” Journal of Steroid Biochemistry and Molecular Biology, vol. 86, no. 2, pp. 201–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Evans, “Functional and metabolic consequences of sarcopenia,” Journal of Nutrition, vol. 127, no. 5, pp. 9985–10035, 1997. View at Scopus
  25. A. L. Goldberg and H. M. Goodman, “Relationship between cortisone and muscle work in determining muscle size,” Journal of Physiology, vol. 200, no. 3, pp. 667–675, 1969. View at Scopus
  26. T. Seene and A. Viru, “The catabolic effect of glucocorticoids on different types of skeletal muscle fibres and its dependence upon muscle activity and interaction with anabolic steroids,” Journal of Steroid Biochemistry, vol. 16, no. 2, pp. 349–352, 1982. View at Publisher · View at Google Scholar · View at Scopus
  27. R. C. Hickson and J. R. Davis, “Partial prevention of glucocorticoid-induced muscle atrophy by endurance training,” The American Journal of Physiology, vol. 241, no. 3, pp. E226–E232, 1981. View at Scopus
  28. R. C. Hickson, T. M. Galassi, J. A. Capaccio, and R. T. Chatterton, “Limited resistance of hypertrophied skeletal muscle to glucocorticoids,” Journal of Steroid Biochemistry, vol. 24, no. 6, pp. 1179–1183, 1986. View at Scopus
  29. S. M. Czerwinski-Helms and R. C. Hickson, “Specificity of activated glucocorticoid receptor expression in heart and skeletal muscle types,” Biochemical and Biophysical Research Communications, vol. 142, no. 2, pp. 322–328, 1987. View at Scopus
  30. T. Seene, P. Kaasik, and M. Umnova, “Structural rearrangements in contractile apparatus and resulting skeletal muscle remodelling: effect of exercise training,” Journal of Sports Medicine and Physical Fitness, vol. 49, no. 4, pp. 410–423, 2009. View at Scopus
  31. T. Seene, P. Kaasik, and K. Alev, “Muscle protein turnover in endurance training: a review,” International Journal of Sports Medicine, vol. 32, no. 12, pp. 905–911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Hood, “Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 465–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Ljubicic, A. M. Joseph, A. Saleem et al., “Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging,” Biochimica et Biophysica Acta, vol. 1800, no. 3, pp. 223–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Seene, “Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 50, no. 1-2, pp. 1–4, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Dardevet, C. Sornet, D. Taillandier, I. Savary, D. Attaix, and J. Grizard, “Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging,” Journal of Clinical Investigation, vol. 96, no. 5, pp. 2113–2119, 1995. View at Scopus
  36. D. Dardevet, C. Sornet, I. Savary, E. Debras, P. Patureau-Mirand, and J. Grizard, “Glucocorticoid effects on insulin- and IGF-I-regulated muscle protein metabolism during aging,” Journal of Endocrinology, vol. 156, no. 1, pp. 83–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. J. N. Artaza, S. Bhasin, C. Mallidis, W. Taylor, K. Ma, and N. F. Gonzalez-Cadavid, “Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells,” Journal of Cellular Physiology, vol. 190, no. 2, pp. 170–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Seene, M. Umnova, K. Alev, and A. Pehme, “Effect of glucocorticoids on contractile apparatus of rat skeletal muscle,” Journal of Steroid Biochemistry, vol. 29, no. 3, pp. 313–317, 1988. View at Scopus
  39. P. Kaasik, M. Umnova, A. Pehme et al., “Ageing and dexamethasone associated sarcopenia: peculiarities of regeneration,” Journal of Steroid Biochemistry and Molecular Biology, vol. 105, no. 1–5, pp. 85–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. K. R. Short and K. S. Nair, “The effect of age on protein metabolism,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 3, no. 1, pp. 39–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Järva, K. Alev, and T. Seene, “Myosin heavy chain composition in regenerating skeletal muscle grafts,” Basic and Applied Myology, vol. 7, no. 2, pp. 137–141, 1997.
  42. J. Järva, K. Alev, and T. Seene, “The effect of autografting on the myosin composition in skeletal muscle fibers,” Muscle & Nerve, vol. 20, no. 6, pp. 718–727, 1997.
  43. T. Seene, M. Umnova, P. Kaasik, K. Alev, and A. Pehme, “Overtraining injuries in athletic population,” in Skeletal Muscle Damage and Repair, P. Tiidus, Ed., Human Kinetics Books, Champaign, Ill, USA, 2008.
  44. A. M. Ahtikoski, E. M. Riso, S. O. A. Koskinen, J. Risteli, and T. E. S. Takala, “Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise,” Pflugers Archiv, vol. 448, no. 1, pp. 123–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. E. M. Riso, A. Ahtikoski, K. Alev, P. Kaasik, A. Pehme, and T. Seene, “Relationship between extracellular matrix, contractile apparatus, muscle mass and strength in case of glucocorticoid myopathy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 108, no. 1-2, pp. 117–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Everts, E. van der Zee, L. Creemers, and W. Beertsen, “Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling,” Histochemical Journal, vol. 28, no. 4, pp. 229–245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Kovanen, H. Suominen, and E. Heikkinen, “Mechanical properties of fast and slow skeletal muscle with special reference to collagen and endurance training,” Journal of Biomechanics, vol. 17, no. 10, pp. 725–735, 1984. View at Scopus
  48. V. Kovanen, H. Suominen, and E. Heikkinen, “Collagen of slow twitch and fast twitch muscle fibres in different types of rat skeletal muscle,” European Journal of Applied Physiology and Occupational Physiology, vol. 52, no. 2, pp. 235–242, 1984. View at Scopus
  49. A. Pehme, K. Alev, P. Kaasik, and T. Seene, “Age-related changes in skeletal-muscle myosin heavy-chain composition: effect of mechanical loading,” Journal of Aging and Physical Activity, vol. 12, no. 1, pp. 29–44, 2004. View at Scopus
  50. A. E. Barani, A. C. Durieux, O. Sabido, and D. Freyssenet, “Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells,” Journal of Applied Physiology, vol. 95, no. 5, pp. 2089–2098, 2003. View at Scopus
  51. S. Machida and F. W. Booth, “Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals,” Experimental Gerontology, vol. 39, no. 10, pp. 1521–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. B. M. Carlson, “Regeneration of entire skeletal muscles,” Federation Proceedings, vol. 45, no. 5, pp. 1456–1460, 1986. View at Scopus
  53. E. Shultz and K. Darr, “The role of satellite cells in adaptive or induced fiber transformations,” in The Dynamic State of Muscle Fibers, D. Pette, Ed., pp. 667–681, Walter De Gruyter, Berlin, Germany, 1990.
  54. T. P. White and S. T. Devor, “Skeletal muscle regeneration and plasticity of grafts,” Exercise and Sport Sciences Reviews, vol. 21, pp. 263–295, 1993. View at Scopus
  55. T. Seene, P. Kaasik, K. Alev, A. Pehme, and E. M. Riso, “Composition and turnover of contractile proteins in volume-overtrained skeletal muscle,” International Journal of Sports Medicine, vol. 25, no. 6, pp. 438–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Balagopal, O. E. Rooyackers, D. B. Adey, P. A. Ades, and K. S. Nair, “Effects of aging on in vivo synthesis of skeletal muscle myosin heavy- chain and sarcoplasmic protein in humans,” American Journal of Physiology, vol. 273, no. 4, pp. E790–E800, 1997. View at Scopus
  57. S. Welle, K. Bhatt, and C. Thornton, “Polyadenylated RNA, actin mRNA, and myosin heavy chain mRNA in young and old human skeletal muscle,” American Journal of Physiology, vol. 270, no. 2, pp. E224–E229, 1996. View at Scopus
  58. B. C. Clark and T. M. Manini, “Sarcopenia dynapenia,” Journals of Gerontology A, vol. 63, no. 8, pp. 829–834, 2008. View at Scopus
  59. T. M. Manini and B. C. Clark, “Dynapenia and aging: an uptate,” Journal of Gerontology, vol. 67A, no. 1, pp. 28–40, 2012. View at Publisher · View at Google Scholar
  60. T. Trappe, “Influence of aging and long-term unloading on the structure and function of human skeletal muscle,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 459–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. B. von Bonsdorff and T. Rantanen, “Progression of functional limitations in relation to physical activity: a life course approach,” European Review of Aging and Physical Activity, vol. 8, no. 1, pp. 23–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Mechling and Y. Netz, “Aging and inactivity-capitalizing on the protective effect of planned physical activity in old age,” European Review of Aging and Physical Activity, vol. 6, no. 2, pp. 89–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. W. J. Rejeski and L. R. Brawley, “Functional health: innovations in research on physical activity with older adults,” Medicine and Science in Sports and Exercise, vol. 38, no. 1, pp. 93–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Ducomps, P. Mauriège, B. Darche, S. Combes, F. Lebas, and J. P. Doutreloux, “Effects of jump training on passive mechanical stress and stiffness in rabbit skeletal muscle: role of collagen,” Acta Physiologica Scandinavica, vol. 178, no. 3, pp. 215–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. G. Goldspink, K. Fernandes, P. E. Williams, and D. J. Wells, “Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice,” Neuromuscular Disorders, vol. 4, no. 3, pp. 183–191, 1994. View at Publisher · View at Google Scholar · View at Scopus
  66. S. L. Mcgee, K. J. Mustard, D. G. Hardie, and K. Baar, “Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase α1 following overload in LKB1 knockout mice,” Journal of Physiology, vol. 586, no. 6, pp. 1731–1741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. R. C. Hickson, T. T. Kurowski, J. A. Capaccio, and R. T. Chatterton, “Androgen cytosol binding in exercise-induced sparing of muscle atrophy,” American Journal of Physiology, vol. 247, no. 5, part 1, pp. E597–E603, 1984. View at Scopus
  68. S. M. Czerwinski and R. C. Hickson, “Glucocorticoid receptor activation during exercise in muscle,” Journal of Applied Physiology, vol. 68, no. 4, pp. 1615–1620, 1990. View at Scopus
  69. E.-M. Riso, A. M. Ahtikoski, M. Umnova, et al., “Partial prevention of muscle atrophy in excessive level of glucocorticoids by exercise: effect on contractile proteins and extracellular matrix,” Baltic Journal of Laboratory Animal Science, vol. 13, no. 1, pp. 5–12, 2003.
  70. E. M. Riso, A. M. Ahtikoski, T. E. S. Takala, and T. Seene, “The effect of unloading and reloading on the extracellular matrix in skeletal muscle: changes in muscle strength and motor activity,” Biology of Sport, vol. 27, no. 2, pp. 89–94, 2010. View at Scopus
  71. E. P. Rader and J. A. Faulkner, “Recovery from contraction-induced injury is impaired in weight-bearing muscles of old male mice,” Journal of Applied Physiology, vol. 100, no. 2, pp. 656–661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. A. C. Fry, “The role of resistance exercise intensity on muscle fibre adaptations,” Sports Medicine, vol. 34, no. 10, pp. 663–679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. K. D. Flack, K. P. Davy, M. W. Hulver, et al., “Aging, resistance training, and diabetes prevention,” Journal of Aging Research, vol. 2011, Article ID 127315, 12 pages, 2011. View at Publisher · View at Google Scholar
  74. D. R. Moore, J. E. Tang, N. A. Burd, T. Rerecich, M. A. Tarnopolsky, and S. M. Phillips, “Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise,” Journal of Physiology, vol. 587, no. 4, pp. 897–904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. D. R. Moore, P. J. Atherton, M. J. Rennie, M. A. Tarnopolsky, and S. M. Phillips, “Resistance exercise enhances mTOR and MAPK signalling in human muscle over that seen at rest after bolus protein ingestion,” Acta Physiologica, vol. 201, no. 3, pp. 365–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. J. R. McLester, P. A. Bishop, J. Smith et al., “A series of studies—a practical protocol for testing muscular endurance recovery,” Journal of Strength and Conditioning Research, vol. 17, no. 2, pp. 259–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Fell and A. D. Williams, “The effect of aging on skeletal-muscle recovery from exercise: possible implications for aging athletes,” Journal of Aging and Physical Activity, vol. 16, no. 1, pp. 97–115, 2008. View at Scopus
  78. T. Seene, A. Pehme, K. Alev, P. Kaasik, M. Umnova, and M. Aru, “Effects of resistance training on fast- and slow-twitch muscles in rats,” Biology of Sport, vol. 27, no. 3, pp. 221–229, 2010. View at Scopus
  79. Y. Itai, Y. Kariya, and Y. Hoshino, “Morphological changes in rat hindlimb muscle fibres during recovery from disuse atrophy,” Acta Physiologica Scandinavica, vol. 181, no. 2, pp. 217–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Suominen, “Ageing and maximal physical performance,” European Review of Aging and Physical Activity, vol. 8, no. 1, pp. 37–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Sagiv, E. Goldhammer, D. Ben-Sira, and R. Amir, “Factors defining oxygen uptake at peak exercise in aged people,” European Review of Aging and Physical Activity, vol. 7, no. 1, pp. 1–2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Netz, “Type of activity and fitness benefits as moderators of the effect of physical activity on affect in advanced age: a review,” European Review of Aging and Physical Activity, vol. 6, no. 1, pp. 19–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. D. Kuh, E. J. Bassey, S. Butterworth, R. Hardy, and M. E. J. Wadsworth, “Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions,” Journals of Gerontology A, vol. 60, no. 2, pp. 224–231, 2005. View at Scopus
  84. J. M. Guralnik and L. Ferrucci, “Assessing the building blocks of function: utilizing measures of functional limitation,” American Journal of Preventive Medicine, vol. 25, no. 3, pp. 112–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. R. M. Reznick, H. Zong, J. Li et al., “Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis,” Cell Metabolism, vol. 5, no. 2, pp. 151–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. D. M. Thomson, J. D. Brown, N. Fillmore et al., “AMP-activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle,” Journal of Physiology, vol. 587, no. 9, pp. 2077–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. W. W. Winder and D. G. Hardie, “Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise,” American Journal of Physiology, vol. 270, no. 2, pp. E299–E304, 1996. View at Scopus
  88. W. W. Spirduso and D. L. Cronin, “Exercise dose-response effects on quality of life and independent living in older adults,” Medicine and Science in Sports and Exercise, vol. 33, supplement 6, pp. S598–S608, 2001. View at Scopus
  89. A. F. Kramer and K. I. Erickson, “Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function,” Trends in Cognitive Sciences, vol. 11, no. 8, pp. 342–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. R. C. Hickson, “Interference of strength development by simultaneously training for strength and endurance,” European Journal of Applied Physiology and Occupational Physiology, vol. 45, no. 2-3, pp. 255–263, 1980. View at Scopus
  91. K. Inoki, Y. Li, T. Zhu, J. Wu, and K. L. Guan, “TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling,” Nature Cell Biology, vol. 4, no. 9, pp. 648–657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. G. A. Nader, “Concurrent strength and endurance training: from molecules to man,” Medicine and Science in Sports and Exercise, vol. 38, no. 11, pp. 1965–1970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. E. L. Cadore, R. S. Pinto, F. L. R. Lhullier et al., “Physiological effects of concurrent training in elderly men,” International Journal of Sports Medicine, vol. 31, no. 10, pp. 689–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. R. H. Wood, R. Reyes, M. A. Welsch et al., “Concurrent cardiovascular and resistance training in healthy older adults,” Medicine and Science in Sports and Exercise, vol. 33, no. 10, pp. 1751–1758, 2001. View at Scopus
  95. M. Izquierdo, J. Ibañez, K. Häkkinen, W. J. Kraemer, J. L. Larrión, and E. M. Gorostiaga, “Once weekly combined resistance and cardiovascular training in healthy older men,” Medicine and Science in Sports and Exercise, vol. 36, no. 3, pp. 435–443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Karavirta, M. P. Tulppo, D. E. Laaksonen et al., “Heart rate dynamics after combined endurance and strength training in older men,” Medicine and Science in Sports and Exercise, vol. 41, no. 7, pp. 1436–1443, 2009. View at Publisher · View at Google Scholar · View at Scopus